Skip to main content

Table 1 The baseline characteristics of the study subjects

From: Obesity and lipid-related parameters for predicting metabolic syndrome in Chinese elderly population

Variable Male (n = 3077) Female (n = 3645)
  With MetS (n = 999) Without MetS (n = 2078) P value With MetS (n = 1719) Without MetS (n = 1926) P value
Age (years) 70.02 ± 7.21 69.98 ± 7.42 0.885 70.59 ± 7.51 69.70 ± 7.75 < 0.001
Current smoking 94 (9.41%) 129 (6.21%) 0.001 17 (0.99%) 5 (0.26%) 0.005
Alcohol consumption 260 (26.03%) 242 (11.65%) < 0.001 172 (10.01%) 75 (3.89%) < 0.001
Family history of CVD 249 (24.92%) 513 (24.69%) 0.886 535 (31.12%) 423 (21.96%) < 0.001
BMI (kg/m2) 26.02 ± 2.83 23.14 ± 3.05 < 0.001 25.74 ± 3.77 22.58 ± 3.04 < 0.001
WC (cm) 90.6 ± 7.8 81.2 ± 7.8 < 0.001 85.8 ± 8.6 76.7 ± 7.9 < 0.001
WHtR 0.54 ± 0.05 0.49 ± 0.05 < 0.001 0.55 ± 0.06 0.50 ± 0.05 < 0.001
SBP (mmHg) 149 (136, 162) 136 (122, 153) < 0.001 148 (136, 161) 134 (120, 151) < 0.001
DBP (mmHg) 84.6 ± 11.5 79.7 ± 12.3 < 0.001 84.9 ± 11.2 79.8 ± 12.1 < 0.001
FPG (mmol/L) 6.3 (5.7, 7.4) 5.5 (5.1, 6.0) < 0.001 6.0 (5.6, 6.9) 5.4 (5.1, 5.8) < 0.001
TC (mmol/L) 4.81 (4.21, 5.45) 4.72 (4.16, 5.33) 0.016 5.27 (4.64, 5.91) 5.36 (4.75, 5.94) 0.003
TG (mmol/L) 2.11 ± 1.57 1.09 ± 0.56 < 0.001 2.03 ± 1.35 1.15 ± 0.49 < 0.001
HDL-C (mmol/L) 1.02 ± 0.20 1.25 ± 0.25 < 0.001 1.17 ± 0.20 1.46 ± 0.27 < 0.001
LDL-C (mmol/L) 3.01 (2.47, 3.56) 3.00 (2.47, 3.54) 0.795 3.24 (2.66, 3.85) 3.37 (2.77, 3.89) 0.005
TG/HDL-C 2.20 ± 2.07 0.93 ± 0.60 < 0.001 1.88 ± 1.65 0.84 ± 0.48 < 0.001
LAP 51.71 ± 38.60 18.27 ± 13.53 < 0.001 55.25 ± 40.15 21.75 ± 13.16 < 0.001
VAI 2.84 ± 2.61 1.16 ± 0.75 < 0.001 3.54 ± 3.16 1.52 ± 0.88 < 0.001
  1. Data are expressed as mean ± standard deviation, median (interquartile range 25–75%), or counts (percentages)
  2. MetS metabolic syndrome, CVD cardiovascular disease, BMI body mass index, WC waist circumference, WHtR waist-to-height ratio, SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, LAP lipid accumulation product, VAI visceral adiposity index